Follow us on :


Journal of Drug Development

Online ISSN: 2515-9194

Akira Sugawara (Editor-in-Chief)

University Graduate School of Medicine, Japan

The Journal of Drug Development is aimed to serve as the hub of high impact scientific information in the emerging field of drug science and development. The journal focusses on the needs of the researchers and dedicated to serve the scientific and medical community and the widely scientifically interested world audience by publishing most valuable and relevant research to empower researchers, students, teachers and professionals.

Journal of Drug Development published original research articles, review articles, and clinical studies on all aspects of drug development i.e from pharmaceutical dosage forms and the most advanced drug delivery systems. JDD is devoted to publishing advances in the nature, action, efficacy, and evaluation of drugs.

The journal is honored to invite all researchers to publish their innovative and thought-provoking research or review on important developments in the field of drug sciences, novel drugs, basic and clinical aspects of drugs.

The articles can be accessed online immediately on their publication. We are committed to providing authors with a rapid, fair, and constructive review process, with a goal of giving the majority of first decisions within two weeks.

Journal of Drug Development is now open for submissions. You can submit your manuscript to: submissions@oatext.com

Please, follow the Instructions for Authors. In the cover letter add the name and e-mail address of 5 proposed reviewers (we can choose them or not).

Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by Journal of Drug Development, is properly cited.

Akira Sugawara


Professor Akira Sugawara belongs to the Department of Molecular Endocrinology, Tohoku University Graduate School of Medicine, Sendai, Japan. He graduated from Tohoku University School of Medicine on 1987 (M.D.) and got Ph.D. on 1991 from Tohoku University Graduate School of Medicine. He performed Postdoctoral Fellowship in William Chin’s laboratory at the Women’s Hospital/Harvard Medical School in Boston from 1991 to 1994. His major is general internal medicine, endocrinology and metabolism and hypertension and nephrology. His research interest are as follows:

  1. molecular biology of nuclear hormone receptors
  2. etiology of high blood pressure
  3. pathophysiology of diabetic nephropathy
  4. gene regulation of aldosterone synthase
  5. epigenetics of hypertension and diabetes mellitus.

Akira Sugawara


Professor Akira Sugawara belongs to the Department of Molecular Endocrinology, Tohoku University Graduate School of Medicine, Sendai, Japan. He graduated from Tohoku University School of Medicine on 1987 (M.D.) and got Ph.D. on 1991 from Tohoku University Graduate School of Medicine. He performed Postdoctoral Fellowship in William Chin’s laboratory at the Women’s Hospital/Harvard Medical School in Boston from 1991 to 1994. His major is general internal medicine, endocrinology and metabolism and hypertension and nephrology. His research interest are as follows:

  1. molecular biology of nuclear hormone receptors
  2. etiology of high blood pressure
  3. pathophysiology of diabetic nephropathy
  4. gene regulation of aldosterone synthase
  5. epigenetics of hypertension and diabetes mellitus.

Editorial Board

Editor-in-Chief

Akira Sugawara

Professor
Department of Molecular Endocrinology
Tohoku University Graduate School of Medicine, Sendai
Japan

Editors

Chunguang Han

Research Center for Materials Science
Nagoya University
Nagoya
Japan

Nats Rajagopalan

Department of Bioproduct R&D
Eli Lilly & Company
USA

Lei Wang

Department of Physiology and Anatomy
North Texas Health Science Center
USA


Chung-Yi Chen

Dean and Professor
School of Medical and Health Sciences
Fooyin University
Taiwan

Chunqi Li

Professor in Toxicology and Pharmacology
Wenzhou Medical University
Co-founder and President
Rex Pharma
China

Vural Fidan

Associate Professor
Department of Otorhinolaryngology
Yunus Emre Government Hospital
Turkey


Tarek Mohamed Kamal

Professor
Faculty of Pharmacy
Biochemistry Department
Cairo University

Sophie Laurent

Associate Professor
University of Mons Head of General, Organic and Biomedical Chemistry
NMR and Molecular Imaging Lab

Rati Kailash Prasad Tripathi

Assistant Professor
Department of Pharmaceutical Chemistry
Teerthanker Mahaveer University
India


Poonam Parashar

Department of Pharmaceutical Sciences
School of Bio-Sciences & Bio-technology
Babasaheb Bhimrao Ambedkar University
India

Sudisha Jogaiah

Assistant Professor
Plant Healthcare and Diagnostic Center
PG Department of Studies in Biotechnology and Microbiology
Karnataka University
Karnataka

Biswajit Mukherjee

Professor
Department of Pharmaceutical Technology
Jadavpur University
India


Ravi Kant Upadhyay

Professor
Department of Zoology
Deen Dayal Upadhyaya Gorakhpur University
India

In Press


Will be updated soon.

Current Issue


Will be updated soon.

Archive


Will be updated soon.

Submit Manuscript


Journal of Drug Development is now open for submissions. You can submit your manuscript to: submissions@oatext.com

Publication Charges


Journal of Drug Development is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Journal of Drug Development are GBP 690.

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

  • Recover capitalization costs;
  • Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
  • Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

  1. Wire/Bank transfer
  2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.